SmartFinancial Announces Results for the First Quarter 2024
KNOXVILLE, Tenn., April 22, 2024 (GLOBE NEWSWIRE) — SmartFinancial, Inc. (“SmartFinancial” or the “Company”; NYSE: SMBK), today announced net income […]
Parker to Announce Fiscal 2024 Third Quarter Earnings on May 2; Conference Call and Webcast Scheduled for 11 a.m. Eastern Time
CLEVELAND, April 22, 2024 (GLOBE NEWSWIRE) — Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, […]
Scorpius Holdings Announces Receipt of Filing Delinquency Notification
DURHAM, N.C., April 22, 2024 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufacturing […]
TSX News -
Finning to report Q1 2024 results on May 6 and hold investor call on May 7, 2024
VANCOUVER, British Columbia, April 22, 2024 (GLOBE NEWSWIRE) — Finning International Inc. (TSX: FTT) (“Finning”) will report Q1 2024 results […]
Lithium Argentina to Release First Quarter 2024 Results on May 13, 2024
VANCOUVER, British Columbia, April 22, 2024 (GLOBE NEWSWIRE) — Lithium Americas (Argentina) Corp. (TSX: LAAC) (NYSE: LAAC) (“Lithium Argentina” or […]
First Bank Announces First Quarter 2024 Net Income of $12.5 Million
HAMILTON, N.J., April 22, 2024 (GLOBE NEWSWIRE) — First Bank (Nasdaq Global Market: FRBA) (the Bank) today announced results for […]
Theriva™ Biologics presentará datos preclínicos que apoyan la sinergia potencial entre el VCN-01 y los regímenes de quimioterapia de primera línea contra el cáncer de páncreas en la 27ª Reunión Anual de la Sociedad Americana de Terapia Celular y Genética
– El principal producto candidato, el VCN-01, en combinación con irinotecán liposomal, demostró mayores efectos antitumorales en un xenoinjerto pancreático […]
Theriva™ Biologics to Present Preclinical Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell and Gene Therapy 27th Annual Meeting
– Lead product candidate, VCN-01 in combination with liposomal irinotecan demonstrated enhanced anti-tumor effects in a human pancreatic mouse xenograft– […]
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) — ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated […]
iLearningEngines Reports Fourth Quarter and Full Year 2023 Results
Fourth quarter revenue grew 39% year-over-year to $116 million Posts record full year revenue of $421 million, up 36% year-over-year, […]
